Bulletin
Investor Alert

New York Markets Open in:

Global Blood Therapeutics Inc.

NAS: GBT

GO
/marketstate/country/us

After Hours

GBT
/zigman2/quotes/206019615/composite

$

30.15

Change

-0.16 -0.53%

Volume

Volume 8,928

Oct 19, 2021, 6:24 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/206019615/composite

Previous close

$ 30.71

$ 30.31

Change

-0.40 -1.30%

Day low

Day high

$30.23

$31.53

Open
Open: 30.70

52 week low

52 week high

$25.11

$63.03

Open

Market cap

$1.92B

Average volume

1.15M

P/E ratio

N/A

Rev. per Employee

$318,260

EPS

-4.30

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/gbt

MarketWatch News on GBT

  1. Global Blood Therapeutics downgraded to neutral from overweight at JPMorgan, price target cut to $36 from $70

    11:29 a.m. June 28, 2021

    - Tonya Garcia

  2. Global Blood Therapeutics reiterated as outperform with $152 price target at Wedbush

    8:48 a.m. Dec. 11, 2020

    - Ciara Linnane

  3. Global Blood Therapeutics downgraded to market perform from outperform at Raymond James

    9:15 a.m. Nov. 6, 2020

    - Tomi Kilgore

  4. Sickle-Cell Data Look Good for Crispr, bluebird, Global Blood

    3:12 p.m. Nov. 5, 2020

    - Barron's Online

  5. Global Blood Therapeutics started at outperform with $102 stock price target at Evercore ISI

    6:11 a.m. Oct. 6, 2020

    - Tomi Kilgore

  6. 5 Biotech Stocks That Could Be Worth a Look

    10:44 p.m. Aug. 26, 2020

    - Barron's Online

  7. Global Blood Therapeutics initiated at outperform with $56 price target at Raymond James

    8:16 a.m. Aug. 25, 2020

    - Tonya Garcia

  8. These Companies Are Seeking a Cure for Sickle Cell

    11:53 a.m. July 25, 2020

    - Barron's Online

  9. Global Blood Therapeutics started at buy with $112 stock price target at Stifel Nicolaus

    7:56 a.m. April 28, 2020

    - Tomi Kilgore

  10. Global Blood Therapeutics downgraded to hold from buy at SunTrust RH

    9:04 a.m. Jan. 31, 2020

    - Tomi Kilgore

  11. Global Blood Therapeutics stock price target cut to $75 from $110 at SunTrust RH

    9:04 a.m. Jan. 31, 2020

    - Tomi Kilgore

  12. Global Blood Therapeutics stock price target raised to $100 from $90 at SunTrust RH

    7:19 a.m. Oct. 14, 2019

    - Tomi Kilgore

  13. Here’s your guide to the upcoming biotechnology takeover wave

    5:48 p.m. Jan. 15, 2019

    - Michael Brush

  14. Charting a bull-trend pullback, S&P 500 hesitates at major resistance

    11:54 a.m. Aug. 23, 2018

    - Michael Ashbaugh

  15. Loading more headlines...
/news/nonmarketwatch/company/us/gbt

Other News on GBT

  1. Tracking Baker Brothers Portfolio - Q2 2021 Update

    12:54 a.m. Oct. 5, 2021

    - Seeking Alpha

  2. Global Blood Therapeutics (GBT) Corporate Presentation

    3:56 p.m. Sept. 10, 2021

    - Seeking Alpha

  3. A Trio of Stocks Growing Capex Fast

    11:53 a.m. Sept. 9, 2021

    - GuruFocus.com

  4. Why Shares of Global Blood Therapeutics Are Soaring Today

    1:26 p.m. Aug. 23, 2021

    - Motley Fool

  5. Why Global Blood Therapeutics Is Rallying Today

    1:18 p.m. Aug. 4, 2021

    - Motley Fool

  6. Global Blood's (GBT) Q2 Earnings Beat, Revenues Rise Y/Y

    10:04 a.m. Aug. 4, 2021

    - Zacks.com

  7. Loading more headlines...
/news/pressrelease/company/us/gbt

Press Releases on GBT

  1. GBT Announces New Employment Inducement Grants

    8:09 a.m. Oct. 7, 2021

    - GlobeNewswire

  2. GBT Announces New Employment Inducement Grants

    8:00 a.m. Sept. 9, 2021

    - GlobeNewswire

  3. GBT Announces Participation in Upcoming Investor Conferences

    8:00 a.m. Sept. 2, 2021

    - GlobeNewswire

  4. GBT Announces New Employment Inducement Grants

    8:00 a.m. Aug. 12, 2021

    - GlobeNewswire

  5. Hemoglobinopathies Market Size, Share, Trends, Analysis and Forecast 2027

    8:46 a.m. Aug. 6, 2021

    - Market Insight Reports

  6. Loading more headlines...

Rates »

Link to MarketWatch's Slice.